Pharma advances non-opioid pain drugs

The American pharmaceutical industry has been making significant progress in developing medications that can treat severe pain as effectively as opioids without the risk of addiction.

Earlier this year, drug maker Vertex received approval from the U.S. Food and Drug Administration (FDA) to market the non-opioid painkiller suzetrigine, under the brand name Journavx, for the treatment of acute pain. This is the first time in 25 years that the FDA has approved a new type of painkilling medication, and the first of potentially many non-opioid pain treatments to become available to patients.

Why it matters

RFK Jr. unveils campaign to boost wearable health devices

Health and Human Services Secretary Robert F. Kennedy Jr. announced one of the largest advertising campaigns in HHS history. The goal: encourage Americans to use wearable health devices like heart rate monitors and glucose trackers. Kennedy said he wants every American to be wearing one within four years.

Why it matters

Plastics are everywhere — should you be concerned?

You will almost certainly eat or drink plastic this week.

While the U.S. Food and Drug Administration has concluded that the current scientific evidence “does not demonstrate that levels of microplastics or nanoplastics detected in food pose a risk to human health,” a wide range of studies in recent years have found plastic in food and drink, and in most human organs.

Read more

Brodeur: Building an 'accountability wall' around Florida’s Medicaid program

President Trump’s rallying cry for a “Big, Beautiful Bill” captured a simple yet powerful principle: every government dollar should build something worthy of public trust. Florida embraces that spirit as it confronts the rising cost and complexity of Medicaid, a program that now consumes nearly 40% of all state Health and Human Services spending, and roughly $33.4 billion in the FY 2024‑25 budget.

Read more